Immunotherapy in Tumors: Integrated Information to Outsmart Cancer

If it wasn’t such a devastating disease, there would be memes about how super-smart cancer is. Cancer cells can express neoantigens — tumor-specific, mutated peptides — that, when processed and presented by the MHC to T cells, mount an adequate...

/ December 2, 2019

Spatial Profiling using the GeoMx RNA Assay for NGS Readout: Robust Technology for Identification of Novel Biomarkers and Early Detection of Melanoma

Early diagnosis of melanoma is critical for improved clinical outcomes and survival of patients. Yet disagreement in traditional histology-based diagnosis frequently occurs.  Despite currently available molecular technologies, melanomas characterized by low cellularity and heterogeneity can hinder accurate diagnosis. To address...

/ November 19, 2019

A Transcriptomic Solution Customized for Your Every Need

The flexibility of the NanoString® nCounter® platform has been designed to accommodate a wide range of organisms, molecular targets, and sample inputs. Researchers can request “made-to-order” Custom CodeSets for up to 800 project-specific mRNA targets. In doing so, they can...

/ November 11, 2019

The Era of Spatial Transcriptomics Falls into Place at SITC 2019

It’s that time of year again when Fall is upon us and in full swing: leaves are falling off the trees, Halloween has come and gone, pumpkin spice lattes are on every corner, and thousands of immuno-oncology researchers descend on...

/ November 8, 2019

Meet NanoString Scientists at the AMP 2019 Annual Meeting & Expo

When Elaine Lyon, Ph.D., a scientist on the board of the Association for Molecular Pathology (AMP) was asked why she is involved with AMP, its activities and initiatives, she quoted the famous Captain James T. Kirk from Star Trek and...

/ November 4, 2019